# Molecular Assessment for Gastro-Esophageal Cancer

> **NCT06346054** · NA · RECRUITING · sponsor: **KU Leuven** · enrollment: 1000 (estimated)

## Conditions studied

- Esophageal Cancer
- Gastric Cancer
- Barrett Esophagus

## Interventions

- **DIAGNOSTIC_TEST:** Breath analysis
- **DIAGNOSTIC_TEST:** Blood analysis

## Key facts

- **NCT ID:** NCT06346054
- **Lead sponsor:** KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2029-07-01
- **Final completion:** 2029-07-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06346054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06346054, "Molecular Assessment for Gastro-Esophageal Cancer". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT06346054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*